C2639 Brachytx, non-stranded,i-125

Brachytherapy source, non-stranded, iodine-125, per source

Medically Unlikely Edits (effective October 1, 2026)

Payer policies and prior authorization for C2639

Payer coverage policies that name C2639

C2639 appears in 2 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi.

PayerPolicyRole in policyReviewedDocument
AetnaBrachytherapy (0371)covered if criteria are metMay 20, 2026payer document
Blue Cross & Blue Shield of MississippiBrachytherapy For Clinically Localized Prostate Cancer Using Permanently Implanted Seeds (L.8.01.417)covered if criteria are metpayer document

Medicaid fee-for-service

  • AZ: $34.81 (asc), effective Oct 1, 2026
  • IN: $0.00 (professional, Advanced Practice Nurse (85%), non-facility), effective Sep 21, 2018
  • KY: $36.64 (asc), effective Jan 1, 2026
  • MS: $27.23 (comprehensive), effective Jul 1, 2026
  • ND: $0.00 (physician), effective Aug 1, 2026
  • OK: $32.63 (asc), effective Jan 1, 2026
  • VT: $27.85 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $15.86 (outpatient_hospital_apc, Ambulatory Surgical Centers), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.